RYTM - Rhythm Pharmaceuticals Inc. (RYTM) CEO David Meeker on Q3 2021 Results - Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2021 Earnings Conference Call Nov 02, 2021 08:00 AM ET Company Participants David Connolly - Head of Investor Relations & Corporate Communications David Meeker - Chairman, President & Chief Executive Officer Linda Shapiro - Chief Medical Officer Jennifer Chien - Executive Vice President, Head of North America Hunter Smith - Chief Financial Officer Conference Call Participants Phil Nadeau - Cowen and Co. Joseph Stringer - Needham & Company Corinne Jenkins - Goldman Sachs Presentation Operator Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to our speaker today, David Connolly with Rhythm Pharmaceuticals. Please

For further details see:

Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q3 2021 Results - Earnings Call Transcript